Literature DB >> 3851647

Urinary kallikrein excretion in children of parents with essential hypertension.

M Uchiyama, T Otsuka, K Sakai.   

Abstract

Twelve hour urinary kallikrein excretion was measured in 18 healthy children of parents with essential hypertension and in 47 healthy children of parents without this disorder. No statistically significant difference was observed between the two groups of children.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3851647      PMCID: PMC1777512          DOI: 10.1136/adc.60.10.974

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Altered urinary kallikrein excretion in human hypertension.

Authors:  H S Margolis; R Geller; J J Pisano; A Sjoerdsma
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

2.  A new fluorogenic substrate method for the estimation of kallikrein in urine.

Authors:  H Kato; N Adachi; S Iwanaga; K Abe; K Takada; T Kimura; S Sakakibara
Journal:  J Biochem       Date:  1980-04       Impact factor: 3.387

3.  New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.

Authors:  T Morita; H Kato; S Iwanaga; K Takada; T Kimura
Journal:  J Biochem       Date:  1977-11       Impact factor: 3.387

4.  Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up.

Authors:  S H Zinner; H S Margolius; B Rosner; E H Kass
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

  4 in total
  2 in total

Review 1.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Role of Kinins in Hypertension and Heart Failure.

Authors:  Suhail Hamid; Imane A Rhaleb; Kamal M Kassem; Nour-Eddine Rhaleb
Journal:  Pharmaceuticals (Basel)       Date:  2020-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.